Imugene Limited
OTC: IUGNF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Leslie Chong
- Employees
- 5
- Headquarters
- Sydney, Australia
- IPO year
- 2019
- Market cap
- $37.4M
- Website
- https://www.imugene.com
Loading IUGNF…
Loading profile data…Frequently asked questions about IUGNF
What does Imugene Limited (IUGNF) do?
Imugene Limited, an Australian firm specializing in clinical-stage immuno-oncology, is dedicated to conceiving diverse immunotherapies. Its core mission involves activating the immune systems of cancer patients to effectively combat and eradicate malignant growths. The company's primary therapeutic candidate is HER-Vaxx, a vaccine engineered for...
Where does IUGNF trade?
Imugene Limited (IUGNF) trades on the Other OTC.
What sector is IUGNF in?
Imugene Limited (IUGNF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Imugene Limited?
Leslie Chong is the chief executive officer of Imugene Limited (IUGNF).
Where is Imugene Limited headquartered?
Imugene Limited is headquartered in Australia.
Does IUGNF pay a dividend?
Imugene Limited (IUGNF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IUGNF go public?
Imugene Limited (IUGNF) completed its initial public offering in 2019.